ZA200905854B - A medicament for treating chronic obstructive pulmonary disease - Google Patents
A medicament for treating chronic obstructive pulmonary diseaseInfo
- Publication number
- ZA200905854B ZA200905854B ZA200905854A ZA200905854A ZA200905854B ZA 200905854 B ZA200905854 B ZA 200905854B ZA 200905854 A ZA200905854 A ZA 200905854A ZA 200905854 A ZA200905854 A ZA 200905854A ZA 200905854 B ZA200905854 B ZA 200905854B
- Authority
- ZA
- South Africa
- Prior art keywords
- medicament
- pulmonary disease
- chronic obstructive
- obstructive pulmonary
- treating chronic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007059664 | 2007-03-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200905854B true ZA200905854B (en) | 2010-05-26 |
Family
ID=39431212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200905854A ZA200905854B (en) | 2007-03-09 | 2009-08-24 | A medicament for treating chronic obstructive pulmonary disease |
Country Status (20)
Country | Link |
---|---|
US (1) | US20100048621A1 (ko) |
EP (1) | EP2120904A1 (ko) |
JP (1) | JP5265580B2 (ko) |
KR (1) | KR101442874B1 (ko) |
CN (1) | CN101631538B (ko) |
AR (1) | AR065588A1 (ko) |
AU (1) | AU2008225372B2 (ko) |
BR (1) | BRPI0808344A2 (ko) |
CA (1) | CA2678920C (ko) |
HK (1) | HK1140136A1 (ko) |
IL (1) | IL200436A0 (ko) |
MX (1) | MX2009009634A (ko) |
MY (1) | MY151196A (ko) |
NZ (1) | NZ579186A (ko) |
RU (1) | RU2451507C2 (ko) |
SG (1) | SG179440A1 (ko) |
TW (1) | TWI352593B (ko) |
UA (1) | UA95830C2 (ko) |
WO (1) | WO2008111662A1 (ko) |
ZA (1) | ZA200905854B (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108299263B (zh) | 2018-01-30 | 2020-12-01 | 北京德默高科医药技术有限公司 | 一种普罗布考衍生物及其制备方法与应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5535019A (en) | 1978-09-01 | 1980-03-11 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
JPS5649378A (en) | 1979-08-25 | 1981-05-02 | Otsuka Pharmaceut Co Ltd | Tetrazolylalkoxycarbostyril derivative |
JP2574099B2 (ja) | 1992-05-21 | 1997-01-22 | 大塚製薬株式会社 | アレルギー疾患治療剤 |
JPH10175864A (ja) | 1996-12-16 | 1998-06-30 | Otsuka Pharmaceut Co Ltd | 慢性閉塞性肺疾患治療剤 |
US6852878B2 (en) * | 1998-05-14 | 2005-02-08 | Atherogenics, Inc. | Thioketals and thioethers for inhibiting the expression of VCAM-1 |
WO1999024400A1 (en) * | 1997-11-10 | 1999-05-20 | Vyrex Corporation | Probucol esters and uses thereof |
US7323496B2 (en) * | 1999-11-08 | 2008-01-29 | Theracos, Inc. | Compounds for treatment of inflammation, diabetes and related disorders |
ITMI20020597A1 (it) * | 2002-03-22 | 2003-09-22 | Nicox Sa | Derivati del probucolo |
CA2492433A1 (en) * | 2002-07-12 | 2004-01-22 | Artherogenics, Inc. | Organic amine salts of poorly soluble probucol esters and ethers |
WO2005112914A2 (en) * | 2004-04-20 | 2005-12-01 | Atherogenics, Inc. | Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease |
KR101299320B1 (ko) * | 2005-09-15 | 2013-09-03 | 오츠카 세이야쿠 가부시키가이샤 | 초과산화물 억제제 효과를 갖는 프로부콜 및테트라졸릴알콕시-디히드로카르보스티릴 유도체를 함유하는조합 약물 |
-
2008
- 2008-03-03 AR ARP080100890A patent/AR065588A1/es unknown
- 2008-03-07 US US12/530,422 patent/US20100048621A1/en not_active Abandoned
- 2008-03-07 TW TW097107995A patent/TWI352593B/zh not_active IP Right Cessation
- 2008-03-07 NZ NZ579186A patent/NZ579186A/en not_active IP Right Cessation
- 2008-03-07 WO PCT/JP2008/054689 patent/WO2008111662A1/en active Application Filing
- 2008-03-07 MX MX2009009634A patent/MX2009009634A/es active IP Right Grant
- 2008-03-07 JP JP2009552375A patent/JP5265580B2/ja not_active Expired - Fee Related
- 2008-03-07 CA CA2678920A patent/CA2678920C/en not_active Expired - Fee Related
- 2008-03-07 AU AU2008225372A patent/AU2008225372B2/en not_active Ceased
- 2008-03-07 EP EP08722086A patent/EP2120904A1/en not_active Withdrawn
- 2008-03-07 RU RU2009137378/15A patent/RU2451507C2/ru not_active IP Right Cessation
- 2008-03-07 UA UAA200910237A patent/UA95830C2/ru unknown
- 2008-03-07 CN CN2008800077951A patent/CN101631538B/zh not_active Expired - Fee Related
- 2008-03-07 MY MYPI20093632 patent/MY151196A/en unknown
- 2008-03-07 SG SG2012015657A patent/SG179440A1/en unknown
- 2008-03-07 KR KR1020097020986A patent/KR101442874B1/ko not_active IP Right Cessation
- 2008-03-07 BR BRPI0808344-4A patent/BRPI0808344A2/pt not_active IP Right Cessation
-
2009
- 2009-08-17 IL IL200436A patent/IL200436A0/en unknown
- 2009-08-24 ZA ZA200905854A patent/ZA200905854B/xx unknown
-
2010
- 2010-06-25 HK HK10106278.8A patent/HK1140136A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MY151196A (en) | 2014-04-30 |
UA95830C2 (ru) | 2011-09-12 |
US20100048621A1 (en) | 2010-02-25 |
CA2678920C (en) | 2013-10-29 |
CN101631538B (zh) | 2011-11-16 |
SG179440A1 (en) | 2012-04-27 |
JP5265580B2 (ja) | 2013-08-14 |
EP2120904A1 (en) | 2009-11-25 |
AR065588A1 (es) | 2009-06-17 |
IL200436A0 (en) | 2010-04-29 |
CA2678920A1 (en) | 2008-09-18 |
TW200836734A (en) | 2008-09-16 |
JP2010520872A (ja) | 2010-06-17 |
RU2451507C2 (ru) | 2012-05-27 |
AU2008225372A1 (en) | 2008-09-18 |
BRPI0808344A2 (pt) | 2014-07-29 |
NZ579186A (en) | 2011-05-27 |
CN101631538A (zh) | 2010-01-20 |
TWI352593B (en) | 2011-11-21 |
KR101442874B1 (ko) | 2014-09-19 |
AU2008225372B2 (en) | 2012-12-20 |
HK1140136A1 (en) | 2010-10-08 |
WO2008111662A1 (en) | 2008-09-18 |
RU2009137378A (ru) | 2011-04-20 |
MX2009009634A (es) | 2009-09-22 |
KR20090119988A (ko) | 2009-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2242529A4 (en) | OPERATING INSTRUMENTS FOR GENERATING PNEUMOSTOMAS AND TREATING CHRONIC-OBSTRUCTIVE LUNG DISEASE | |
HK1255942A1 (zh) | 用於患者接口的鼻枕 | |
BR112012015337A2 (pt) | terapia combinada para doença pulmonar obstrutiva crônica | |
GB2465897B (en) | Respiratory disease treatment | |
EP2164505A4 (en) | TREATMENT OF CHRONIC LUNG DISEASE | |
GB0815696D0 (en) | Dual model approach for boiler section cleanlines calculation | |
IL236360A0 (en) | Inhalable medicine | |
BR112012015334A2 (pt) | terapia combinada para doença pulmonar obstrutiva crônica | |
PT2247297T (pt) | Tratamento terapêutico para estados pulmonares | |
EP2467138A4 (en) | USE OF AEROSOLIZED ANTIBIOTICS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE | |
EP1875915A4 (en) | THERAPEUTIC AGENT FOR TREATING CHRONIC OBSTRUCTIVE RESPIRATORY DISEASE | |
GB0700645D0 (en) | Targets for disease therapy | |
GB0701456D0 (en) | Treatment for respiratory disease | |
EP2047862A4 (en) | MEDICINE FOR TREATMENT OF NURSE DISEASES | |
HK1140136A1 (en) | A medicament for treating chronic obstructive pulmonary disease | |
EP2210878A4 (en) | THERAPEUTIC AGENT AGAINST TRPV1-MEDIATED DISEASES | |
TH0801001146A (th) | ตัวยาสำหรับการรักษาโรคปอดอุดกั้นเรื้อรัง | |
GB0816025D0 (en) | Medicament for the treatment of chronic obstructive pulmonary disease (COPD) | |
HK1098572A1 (en) | Double inhalation traverse | |
GB0715397D0 (en) | Treatment for joint disease | |
TWI372054B (en) | A pharmaceutical composition for preventing or treating cardiovascular disease | |
GB0722047D0 (en) | A medicament | |
GB0700647D0 (en) | Targets for disease therapy | |
GB0700646D0 (en) | Targets for disease therapy | |
GB0700644D0 (en) | Targets for disease therapy |